Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1217534
PUBLISHER: QYResearch | PRODUCT CODE: 1217534
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Insights, Forecast to 2029
PUBLISHED:
PAGES: 265 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Contact us about how to customize the report with add-on data.
Market Analysis and Insights:
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) estimated at US$ 139345 million in the year 2023, is projected to reach a revised size of US$ 217203 million by 2029, growing at a CAGR of 7.68% during the forecast period 2023-2029.
The US & Canada market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 37855 million in 2023 to reach $ 50454 million by 2029, at a CAGR of 4.9% during the forecast period of 2023 through 2029.
The China market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 17129 million in 2023 to reach $ 51175 million by 2029, at a CAGR of 20.01% during the forecast period of 2023 through 2029.
The Europe market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) is estimated to increase from $ 28502 million in 2023 to reach $ 36462 million by 2029, at a CAGR of 4.19% during the forecast period of 2024 through 2029.
The global key companies of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, etc. In 2022, the global top five players had a share approximately 14.45% in terms of revenue.
Report Includes
This report presents an overview of global market for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonza, Catalent, Thermo Fisher Scientific, Aenova, Siegfried, Recipharm, Strides Pharma, Piramal, and Boehringer Ingelheim, etc.
By Company
- Catalent
- Thermo Fisher Scientific
- Lonza
- Siegfried
- Recipharm
- Boehringer Ingelheim
- WuXi AppTech
- WuXi Biologics
- Fareva
- Samsung Biologics
- Aenova
- Delpharm
- Strides Pharma
- Piramal
- Famar
- Curia
- Jubilant
- Vetter
- AGC Pharma Chemicals
- Asymchem
- Porton
- Eurofins
- Ascendia Pharmaceuticals
- Ardena
- CPL
- UPM Pharmaceuticals
- FUJIFILM Diosynth Biotechnologies
- Groupe Parima
- TBD Pharmatech
- Avid Bioservices
- NextPharma
- Alcami
- Societal CDMO
- MedPharm
- Euroapi
- BioVectra
- Pfizer CentreOne
- Fermion
- Lundbeck
Segment by Type
- API CDMO
- FDF CDMO
- Packaging CDMO
- Clinical CDMO
Segment by Application
- Pharmaceutical Company
- Biotechnology Company
- Others
By Region
- North America
- United States
- Canada
- Asia (Ex. China)
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- China
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- Latin America, Middle East & Africa
- Mexico
- Brazil
- Middle East
- Africa
- Other
Chapter Outline
- Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
- Chapter 2: Revenue of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
- Chapter 3: Detailed analysis of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
- Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
- Chapter 8: China by Type, and by Application, revenue for each segment.
- Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
- Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
- Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)revenue, gross margin, and recent development, etc.
- Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
- 1.2.2 Clinical CDMO
- 1.2.3 API CDMO
- 1.2.4 FDF CDMO
- 1.2.5 Packaging CDMO
- 1.3 Market by Application
- 1.3.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application: 2018 VS 2022 VS 2029
- 1.3.2 Pharmaceutical Company
- 1.3.3 Biotechnology Company
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Perspective (2018-2029)
- 2.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Growth Trends by Region
- 2.2.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region: 2018 VS 2022 VS 2029
- 2.2.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Historic Market Size by Region (2018-2023)
- 2.2.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Region (2024-2029)
- 2.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Dynamics
- 2.3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Trends
- 2.3.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
- 2.3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Challenges
- 2.3.4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Revenue Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Players
- 3.1.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Players (2018-2023)
- 3.1.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Players (2018-2023)
- 3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Ranking by Revenue, 2021 VS 2022
- 3.4 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Concentration Ratio
- 3.4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue in 2022
- 3.5 Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Head office and Production Site
- 3.6 Founded Date of Global Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Breakdown Data by Type
- 4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Historic Market Size by Type (2018-2023)
- 4.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Breakdown Data by Application
- 5.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Historic Market Size by Application (2018-2023)
- 5.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Application (2024-2029)
6 North America
- 6.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
- 6.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type
- 6.2.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
- 6.2.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
- 6.2.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- 6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application
- 6.3.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
- 6.3.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
- 6.3.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- 6.4 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
- 6.4.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country: 2018 VS 2022 VS 2029
- 6.4.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023)
- 6.4.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2024-2029)
- 6.4.4 United States
- 6.4.5 Canada
7 Europe
- 7.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
- 7.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type
- 7.2.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
- 7.2.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
- 7.2.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- 7.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application
- 7.3.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
- 7.3.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
- 7.3.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- 7.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
- 7.4.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country: 2018 VS 2022 VS 2029
- 7.4.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023)
- 7.4.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2024-2029)
- 7.4.4 Germany
- 7.4.5 France
- 7.4.6 U.K.
- 7.4.7 Italy
- 7.4.8 Russia
8 China
- 8.1 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
- 8.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type
- 8.2.1 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
- 8.2.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
- 8.2.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- 8.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application
- 8.3.1 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
- 8.3.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
- 8.3.3 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
9 Asia (excluding China)
- 9.1 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
- 9.2 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type
- 9.2.1 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
- 9.2.2 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
- 9.2.3 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- 9.3 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application
- 9.3.1 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
- 9.3.2 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
- 9.3.3 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- 9.4 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region
- 9.4.1 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region: 2018 VS 2022 VS 2029
- 9.4.2 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2023)
- 9.4.3 Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2024-2029)
- 9.4.4 Japan
- 9.4.5 South Korea
- 9.4.6 Southeast Asia
- 9.4.7 India
- 9.4.8 Australia
10 Middle East, Africa, and Latin America
- 10.1 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (2018-2029)
- 10.2 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type
- 10.2.1 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023)
- 10.2.2 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029)
- 10.2.3 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- 10.3 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application
- 10.3.1 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023)
- 10.3.2 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029)
- 10.3.3 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- 10.4 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
- 10.4.1 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country: 2018 VS 2022 VS 2029
- 10.4.2 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023)
- 10.4.3 Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2024-2029)
- 10.4.4 Brazil
- 10.4.5 Mexico
- 10.4.6 Middle East
- 10.4.7 Africa
11 Key Players Profiles
- 11.1 Catalent
- 11.1.1 Catalent Company Details
- 11.1.2 Catalent Business Overview
- 11.1.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.1.4 Catalent Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.1.5 Catalent Recent Development
- 11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Company Details
- 11.2.2 Thermo Fisher Scientific Business Overview
- 11.2.3 Thermo Fisher Scientific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.2.5 Thermo Fisher Scientific Recent Development
- 11.3 Lonza
- 11.3.1 Lonza Company Details
- 11.3.2 Lonza Business Overview
- 11.3.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.3.4 Lonza Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.3.5 Lonza Recent Development
- 11.4 Siegfried
- 11.4.1 Siegfried Company Details
- 11.4.2 Siegfried Business Overview
- 11.4.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.4.4 Siegfried Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.4.5 Siegfried Recent Development
- 11.5 Recipharm
- 11.5.1 Recipharm Company Details
- 11.5.2 Recipharm Business Overview
- 11.5.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.5.4 Recipharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.5.5 Recipharm Recent Development
- 11.6 Boehringer Ingelheim
- 11.6.1 Boehringer Ingelheim Company Details
- 11.6.2 Boehringer Ingelheim Business Overview
- 11.6.3 Boehringer Ingelheim Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.6.4 Boehringer Ingelheim Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.6.5 Boehringer Ingelheim Recent Development
- 11.7 WuXi AppTech
- 11.7.1 WuXi AppTech Company Details
- 11.7.2 WuXi AppTech Business Overview
- 11.7.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.7.4 WuXi AppTech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.7.5 WuXi AppTech Recent Development
- 11.8 WuXi Biologics
- 11.8.1 WuXi Biologics Company Details
- 11.8.2 WuXi Biologics Business Overview
- 11.8.3 WuXi Biologics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.8.4 WuXi Biologics Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.8.5 WuXi Biologics Recent Development
- 11.9 Fareva
- 11.9.1 Fareva Company Details
- 11.9.2 Fareva Business Overview
- 11.9.3 Fareva Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.9.4 Fareva Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.9.5 Fareva Recent Development
- 11.10 Samsung Biologics
- 11.10.1 Samsung Biologics Company Details
- 11.10.2 Samsung Biologics Business Overview
- 11.10.3 Samsung Biologics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.10.4 Samsung Biologics Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.10.5 Samsung Biologics Recent Development
- 11.11 Aenova
- 11.11.1 Aenova Company Details
- 11.11.2 Aenova Business Overview
- 11.11.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.11.4 Aenova Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.11.5 Aenova Recent Development
- 11.12 Delpharm
- 11.12.1 Delpharm Company Details
- 11.12.2 Delpharm Business Overview
- 11.12.3 Delpharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.12.4 Delpharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.12.5 Delpharm Recent Development
- 11.13 Strides Pharma
- 11.13.1 Strides Pharma Company Details
- 11.13.2 Strides Pharma Business Overview
- 11.13.3 Strides Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.13.4 Strides Pharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.13.5 Strides Pharma Recent Development
- 11.14 Piramal
- 11.14.1 Piramal Company Details
- 11.14.2 Piramal Business Overview
- 11.14.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.14.4 Piramal Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.14.5 Piramal Recent Development
- 11.15 Famar
- 11.15.1 Famar Company Details
- 11.15.2 Famar Business Overview
- 11.15.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.15.4 Famar Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.15.5 Famar Recent Development
- 11.16 Curia
- 11.16.1 Curia Company Details
- 11.16.2 Curia Business Overview
- 11.16.3 Curia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.16.4 Curia Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.16.5 Curia Recent Development
- 11.17 Jubilant
- 11.17.1 Jubilant Company Details
- 11.17.2 Jubilant Business Overview
- 11.17.3 Jubilant Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.17.4 Jubilant Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.17.5 Jubilant Recent Development
- 11.18 Vetter Pharma
- 11.18.1 Vetter Pharma Company Details
- 11.18.2 Vetter Pharma Business Overview
- 11.18.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.18.4 Vetter Pharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.18.5 Vetter Pharma Recent Development
- 11.19 AGC Pharma Chemicals
- 11.19.1 AGC Pharma Chemicals Company Details
- 11.19.2 AGC Pharma Chemicals Business Overview
- 11.19.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.19.4 AGC Pharma Chemicals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.19.5 AGC Pharma Chemicals Recent Development
- 11.20 Asymchem
- 11.20.1 Asymchem Company Details
- 11.20.2 Asymchem Business Overview
- 11.20.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.20.4 Asymchem Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.20.5 Asymchem Recent Development
- 11.21 Porton
- 11.21.1 Porton Company Details
- 11.21.2 Porton Business Overview
- 11.21.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.21.4 Porton Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.21.5 Porton Recent Development
- 11.22 Eurofins
- 11.22.1 Eurofins Company Details
- 11.22.2 Eurofins Business Overview
- 11.22.3 Eurofins Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.22.4 Eurofins Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.22.5 Eurofins Recent Development
- 11.23 Ascendia Pharmaceuticals
- 11.23.1 Ascendia Pharmaceuticals Company Details
- 11.23.2 Ascendia Pharmaceuticals Business Overview
- 11.23.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.23.4 Ascendia Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.23.5 Ascendia Pharmaceuticals Recent Development
- 11.24 Ardena
- 11.24.1 Ardena Company Details
- 11.24.2 Ardena Business Overview
- 11.24.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.24.4 Ardena Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.24.5 Ardena Recent Development
- 11.25 CPL
- 11.25.1 CPL Company Details
- 11.25.2 CPL Business Overview
- 11.25.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.25.4 CPL Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.25.5 CPL Recent Development
- 11.26 UPM Pharmaceuticals
- 11.26.1 UPM Pharmaceuticals Company Details
- 11.26.2 UPM Pharmaceuticals Business Overview
- 11.26.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.26.4 UPM Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.26.5 UPM Pharmaceuticals Recent Development
- 11.27 FUJIFILM Diosynth Biotechnologies
- 11.27.1 FUJIFILM Diosynth Biotechnologies Company Details
- 11.27.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 11.27.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.27.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.27.5 FUJIFILM Diosynth Biotechnologies Recent Development
- 11.28 Groupe Parima
- 11.28.1 Groupe Parima Company Details
- 11.28.2 Groupe Parima Business Overview
- 11.28.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.28.4 Groupe Parima Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.29 TBD Pharmatech
- 11.29.1 TBD Pharmatech Company Details
- 11.29.2 TBD Pharmatech Business Overview
- 11.29.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.29.4 TBD Pharmatech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.30 Avid Bioservices
- 11.30.1 Avid Bioservices Company Details
- 11.30.2 Avid Bioservices Business Overview
- 11.30.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.30.4 Avid Bioservices Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.31 NextPharma
- 11.31.1 NextPharma Company Details
- 11.31.2 NextPharma Business Overview
- 11.31.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.31.4 NextPharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.31.5 NextPharma Recent Development
- 11.32 Alcami
- 11.32.1 Alcami Company Details
- 11.32.2 Alcami Business Overview
- 11.32.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.32.4 Alcami Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.32.5 Alcami Recent Development
- 11.33 Societal CDMO
- 11.33.1 Societal CDMO Company Details
- 11.33.2 Societal CDMO Business Overview
- 11.33.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.33.4 Societal CDMO Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.33.5 Societal CDMO Recent Development
- 11.34 MedPharm
- 11.34.1 MedPharm Company Details
- 11.34.2 MedPharm Business Overview
- 11.34.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.34.4 MedPharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.35 Euroapi
- 11.35.1 Euroapi Company Details
- 11.35.2 Euroapi Business Overview
- 11.35.3 Euroapi Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.35.4 Euroapi Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.35.5 Euroapi Recent Development
- 11.36 BioVectra
- 11.36.1 BioVectra Company Details
- 11.36.2 BioVectra Business Overview
- 11.36.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.36.4 BioVectra Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.37 Pfizer CentreOne
- 11.37.1 Pfizer CentreOne Company Details
- 11.37.2 Pfizer CentreOne Business Overview
- 11.37.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.37.4 Pfizer CentreOne Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.37.5 Pfizer CentreOne Recent Development
- 11.38 Fermion
- 11.38.1 Fermion Company Details
- 11.38.2 Fermion Business Overview
- 11.38.3 Fermion Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.38.4 Fermion Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.38.5 Fermion Recent Development
- 11.39 Lundbeck
- 11.39.1 Lundbeck Company Details
- 11.39.2 Lundbeck Business Overview
- 11.39.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Introduction
- 11.39.4 Lundbeck Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023)
- 11.39.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer
List of Tables
- Table 1. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
- Table 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
- Table 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
- Table 4. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2023) & (US$ Million)
- Table 5. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region (2018-2023)
- Table 6. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Region (2024-2029) & (US$ Million)
- Table 7. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region (2024-2029)
- Table 8. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Trends
- Table 9. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
- Table 10. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Challenges
- Table 11. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints
- Table 12. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue by Players (2018-2023) & (US$ Million)
- Table 13. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Players (2018-2023)
- Table 14. Global Top Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) as of 2021)
- Table 15. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Industry Ranking 2021 VS 2022
- Table 16. Global 5 Largest Players Market Share by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (CR5 and HHI) & (2018-2023)
- Table 17. Global Key Players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), Headquarters and Production Site
- Table 18. Founded Date of Global Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players
- Table 19. Mergers & Acquisitions, Expansion Plans
- Table 20. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (US$ Million)
- Table 21. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Type (2018-2023)
- Table 22. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Type (2024-2029) & (US$ Million)
- Table 23. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Type (2024-2029)
- Table 24. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (US$ Million)
- Table 25. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Application (2018-2023)
- Table 26. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Forecasted Market Size by Application (2024-2029) & (US$ Million)
- Table 27. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Application (2024-2029)
- Table 28. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (US$ Million)
- Table 29. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (US$ Million)
- Table 30. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (US$ Million)
- Table 31. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (US$ Million)
- Table 32. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
- Table 33. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023) & (US$ Million)
- Table 34. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2024-2029) & (US$ Million)
- Table 35. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (US$ Million)
- Table 36. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (US$ Million)
- Table 37. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (US$ Million)
- Table 38. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (US$ Million)
- Table 39. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
- Table 40. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023) & (US$ Million)
- Table 41. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2024-2029) & (US$ Million)
- Table 42. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (US$ Million)
- Table 43. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (US$ Million)
- Table 44. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (US$ Million)
- Table 45. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (US$ Million)
- Table 46. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (US$ Million)
- Table 47. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (US$ Million)
- Table 48. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (US$ Million)
- Table 49. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (US$ Million)
- Table 50. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
- Table 51. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2018-2023) & (US$ Million)
- Table 52. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region (2024-2029) & (US$ Million)
- Table 53. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2018-2023) & (US$ Million)
- Table 54. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type (2024-2029) & (US$ Million)
- Table 55. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2018-2023) & (US$ Million)
- Table 56. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application (2024-2029) & (US$ Million)
- Table 57. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
- Table 58. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2018-2023) & (US$ Million)
- Table 59. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country (2024-2029) & (US$ Million)
- Table 60. Catalent Company Details
- Table 61. Catalent Business Overview
- Table 62. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 63. Catalent Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 64. Catalent Recent Development
- Table 65. Thermo Fisher Scientific Company Details
- Table 66. Thermo Fisher Scientific Business Overview
- Table 67. Thermo Fisher Scientific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 68. Thermo Fisher Scientific Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 69. Thermo Fisher Scientific Recent Development
- Table 70. Lonza Company Details
- Table 71. Lonza Business Overview
- Table 72. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 73. Lonza Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 74. Lonza Recent Development
- Table 75. Siegfried Company Details
- Table 76. Siegfried Business Overview
- Table 77. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 78. Siegfried Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 79. Siegfried Recent Development
- Table 80. Recipharm Company Details
- Table 81. Recipharm Business Overview
- Table 82. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 83. Recipharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 84. Recipharm Recent Development
- Table 85. Boehringer Ingelheim Company Details
- Table 86. Boehringer Ingelheim Business Overview
- Table 87. Boehringer Ingelheim Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 88. Boehringer Ingelheim Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 89. Boehringer Ingelheim Recent Development
- Table 90. WuXi AppTech Company Details
- Table 91. WuXi AppTech Business Overview
- Table 92. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 93. WuXi AppTech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 94. WuXi AppTech Recent Development
- Table 95. WuXi Biologics Company Details
- Table 96. WuXi Biologics Business Overview
- Table 97. WuXi Biologics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 98. WuXi Biologics Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 99. WuXi Biologics Recent Development
- Table 100. Fareva Company Details
- Table 101. Fareva Business Overview
- Table 102. Fareva Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 103. Fareva Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 104. Fareva Recent Development
- Table 105. Samsung Biologics Company Details
- Table 106. Samsung Biologics Business Overview
- Table 107. Samsung Biologics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 108. Samsung Biologics Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 109. Samsung Biologics Recent Development
- Table 110. Aenova Company Details
- Table 111. Aenova Business Overview
- Table 112. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 113. Aenova Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 114. Aenova Recent Development
- Table 115. Delpharm Company Details
- Table 116. Delpharm Business Overview
- Table 117. Delpharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 118. Delpharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 119. Delpharm Recent Development
- Table 120. Strides Pharma Company Details
- Table 121. Strides Pharma Business Overview
- Table 122. Strides Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 123. Strides Pharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 124. Strides Pharma Recent Development
- Table 125. Piramal Company Details
- Table 126. Piramal Business Overview
- Table 127. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 128. Piramal Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 129. Piramal Recent Development
- Table 130. Famar Company Details
- Table 131. Famar Business Overview
- Table 132. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 133. Famar Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 134. Famar Recent Development
- Table 135. Curia Company Details
- Table 136. Curia Business Overview
- Table 137. Curia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 138. Curia Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 139. Curia Recent Development
- Table 140. Jubilant Company Details
- Table 141. Jubilant Business Overview
- Table 142. Jubilant Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 143. Jubilant Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 144. Jubilant Recent Development
- Table 145. Vetter Pharma Company Details
- Table 146. Vetter Pharma Business Overview
- Table 147. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 148. Vetter Pharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 149. Vetter Pharma Recent Development
- Table 150. AGC Pharma Chemicals Company Details
- Table 151. AGC Pharma Chemicals Business Overview
- Table 152. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 153. AGC Pharma Chemicals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 154. AGC Pharma Chemicals Recent Development
- Table 155. Asymchem Company Details
- Table 156. Asymchem Business Overview
- Table 157. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 158. Asymchem Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 159. Asymchem Recent Development
- Table 160. Porton Company Details
- Table 161. Porton Business Overview
- Table 162. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 163. Porton Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 164. Porton Recent Development
- Table 165. Eurofins Company Details
- Table 166. Eurofins Business Overview
- Table 167. Eurofins Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 168. Eurofins Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 169. Eurofins Recent Development
- Table 170. Ascendia Pharmaceuticals Company Details
- Table 171. Ascendia Pharmaceuticals Business Overview
- Table 172. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 173. Ascendia Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 174. Ascendia Pharmaceuticals Recent Development
- Table 175. Ardena Company Details
- Table 176. Ardena Business Overview
- Table 177. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 178. Ardena Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 179. Ardena Recent Development
- Table 180. CPL Company Details
- Table 181. CPL Business Overview
- Table 182. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 183. CPL Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 184. CPL Recent Development
- Table 185. UPM Pharmaceuticals Company Details
- Table 186. UPM Pharmaceuticals Business Overview
- Table 187. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 188. UPM Pharmaceuticals Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 189. UPM Pharmaceuticals Recent Development
- Table 190. FUJIFILM Diosynth Biotechnologies Company Details
- Table 191. FUJIFILM Diosynth Biotechnologies Business Overview
- Table 192. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 193. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 194. FUJIFILM Diosynth Biotechnologies Recent Development
- Table 195. Groupe Parima Company Details
- Table 196. Groupe Parima Business Overview
- Table 197. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 198. Groupe Parima Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 199. TBD Pharmatech Company Details
- Table 200. TBD Pharmatech Business Overview
- Table 201. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 202. TBD Pharmatech Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 203. Avid Bioservices Company Details
- Table 204. Avid Bioservices Business Overview
- Table 205. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 206. Avid Bioservices Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 207. NextPharma Company Details
- Table 208. NextPharma Business Overview
- Table 209. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 210. NextPharma Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 211. NextPharma Recent Development
- Table 212. Alcami Company Details
- Table 213. Alcami Business Overview
- Table 214. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 215. Alcami Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 216. Alcami Recent Development
- Table 217. Societal CDMO Company Details
- Table 218. Societal CDMO Business Overview
- Table 219. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 220. Societal CDMO Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 221. Societal CDMO Recent Development
- Table 222. MedPharm Company Details
- Table 223. MedPharm Business Overview
- Table 224. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 225. MedPharm Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 226. Euroapi Company Details
- Table 227. Euroapi Business Overview
- Table 228. Euroapi Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 229. Euroapi Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 230. Euroapi Recent Development
- Table 231. BioVectra Company Details
- Table 232. BioVectra Business Overview
- Table 233. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 234. BioVectra Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 235. Pfizer CentreOne Company Details
- Table 236. Pfizer CentreOne Business Overview
- Table 237. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 238. Pfizer CentreOne Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 239. Pfizer CentreOne Recent Development
- Table 240. Fermion Company Details
- Table 241. Fermion Business Overview
- Table 242. Fermion Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 243. Fermion Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 244. Fermion Recent Development
- Table 245. Lundbeck Company Details
- Table 246. Lundbeck Business Overview
- Table 247. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product
- Table 248. Lundbeck Revenue in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Business (2018-2023) & (US$ Million)
- Table 249. Lundbeck Recent Development
- Table 250. Research Programs/Design for This Report
- Table 251. Key Data Information from Secondary Sources
- Table 252. Key Data Information from Primary Sources
- Table 253. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
- Figure 1. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Type, 2018-2029 (US$ Million)
- Figure 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type: 2022
- Figure 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type: 2029
- Figure 4. API CDMO Features
- Figure 5. FDF CDMO Features
- Figure 6. Packaging CDMO Features
- Figure 7. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size Growth Rate by Application, 2018-2029 (US$ Million)
- Figure 8. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application: 2022
- Figure 9. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application: 2029
- Figure 10. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Report Years Considered
- Figure 11. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size (US$ Million), Year-over-Year: 2018-2029
- Figure 12. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size, (US$ Million), 2018 VS 2023 VS 2029
- Figure 13. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region: 2022
- Figure 14. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region: 2029
- Figure 15. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Players in 2022
- Figure 16. The Top 5 Players Market Share by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue in 2022
- Figure 17. The Top 10 Players Market Share by Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue in 2022
- Figure 18. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Market Share by Type (2018-2029)
- Figure 19. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 20. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- Figure 21. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- Figure 22. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2018-2029)
- Figure 23. United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 24. Canada Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 25. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 26. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- Figure 27. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- Figure 28. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Country (2018-2029)
- Figure 29. Germany Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 30. France Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 31. U.K. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 32. Italy Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 33. Russia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 34. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 35. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- Figure 36. China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- Figure 37. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 38. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Type (2018-2029)
- Figure 39. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Application (2018-2029)
- Figure 40. Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Share by Region (2018-2029)
- Figure 41. Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 42. South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 43. Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 44. India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 45. Australia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size YoY Growth (2018-2029) & (US$ Million)
- Figure 46. Middle East, Africa, and Latin America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturin
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.